This page contains a Flash digital edition of a book.
INFECTION PREVENTION


One trend in catheter care is to employ the catheter itself as a weapon against infec- tion. Teleflex offers catheters impregnated with antimicrobials to fight against potential infections. Kathy Conner, Vice President, Global Marketing, Vascular Access, Teleflex Inc., Limerick, PA, described how their cath- eters help to thwart related complications. ”More than 30 studies and reviews prove ARROWg+ard catheter technology’s ability to decrease the incidence of catheter-related BSI, reduce costs, and save lives. For example, ARROWg+ard reduces bacterial colonization of the catheter by 60% and catheter-related infection by 80%. ARROWg+ard Blue PLUS provides proven infection-fighting ability both outside and inside the catheter. Chlorhexidine and silver sulfadiazine continuously prep the subcutaneous catheter tract and kill organisms in places that you simply can’t reach.” Conner also recommends a bundled ap- proach, which has an excellent track record for assisting in reducing rates of infections. “Arrow uses an ErgoPack System for our central venous catheters (CVCs) and periph- erally inserted central catheters, providing 31 essential tools systematically organized for procedural ease. Use of a bundled approach for insertion of central lines is proven to sig- nificantly reduce procedural time and the risk of CRBSI.”


Conner related an experience of a hospital that attributes a lowered rate of CLABSIs to their products. “Patients receiving care in a


West Texas 400-bed county hospital are now facing less risk of CLABSIs. After an internal analysis of their reported medi- cal intensive care unit and burn-unit CLABSI rates, they converted to ARROWg+ard Blue


Curtain Pull


Plus CVCs. This hospital now follows the recom- mendation of the CDC, us- ing antimicrobial catheter technology as part of their HAI reduction plan.” Cook Medical also offers


antimicrobial-impregnated catheters. “Cook Medi- cal’s Spectrum catheters are impregnated with mi- nocycline and rifampin to protect patients against CLABSI, a common and potentially fatal hospital-acquired infection,” said Dan Sirota, Vice President, Interventional Radiology and Critical Care, Cook Medical, Bloomington, IN. “In a challenging clinical environment, a hos- pital that switches to a minocycline+rifampin- impregnated catheter can expect to see a decrease in CLABSI rates, attributable mortal- ity, and CLABSI-related costs.” “What might not be so apparent,” said Sirota, “is that high-performing hospitals can switch to Spectrum to drive incremental improvements in CLABSI rates and still achieve substantial reductions in mortal- ity and cost. For example, in a hospital that places 100 CVCs per month with an average dwell time of 7 days2 and an infection rate of 3.3/1,000 catheter-days, a reduction by 50% would save that hospital 112 bed-days and $231,700 annually.”


Cook


Medical's Spectrum


catheters, with minocycline and


rifampin, protect patients against CLABSI.


“Twenty-one peer-re-


viewed studies confirm process,” said Sirota. “Spectrum is the most effective tool available to


1 2 BD's peripheral IV catheter


technologies limit blood exposure during insertion.


reduce the incidence of BSIs, including gram-positive, gram-negative, and fungal infections in both short- and long-term use. It’s evi- dence of protection no other process or technology can match. Ten years of clinical use and a study of more than 500,000 catheter-days confirm no evidence of bac- terial resistance associated with Spectrum use.”


Products that reduce blood- exposure risks


Inserting catheters puts healthcare workers at risk for blood exposure. Paul Walker, Mar- keting Communications Manager, Medical Surgical Systems, BD Medical, Sandy, UT, talked briefly about the safety features of their catheters that reduce the risk of a blood exposure. “BD has a broad range of peripheral IV catheter technologies designed to limit the exposure of blood during catheter insertion by the healthcare worker. These include BD In- syte Autoguard with Blood Control Technol- ogy, BD Nexiva Closed IV Catheter System, and BD Nexiva Diffusics catheter systems. The BD Nexiva family of catheters all feature pre-attached extension tubing, reducing the number of connections that the clinician is required to make.”


Cheryl Wozniak, Product Manager, Vas- cular Access Systems, B. Braun Medical Inc., Bethlehem, PA, talked about safety features of the Introcan Safety IV catheter and the new Introcan Safety 3 Closed IV Catheter. “From insertion to disposal, B. Braun’s new Introcan Safety 3 closed peripheral IV catheter is designed to protect clinicians and patients while helping facilities save time and money,” said Wozniak.


Advantages include advanced stabilization, which minimizes catheter movement, helping


3


4


Introcan Safety 3 Closed IV Catheter, B. Braun Medical Inc.


For more information about HCL’s line of Infection Prevention Supplies, scan this code with any Smart Phone!


HCL’s exclusive disposable plastic Curtain Pull with handle protects gloved hands by preventing direct contact with a contaminated curtain. To easily attach—just pass the oval biscuit through the small opening along with the curtain material and twist into place.


Call Free: 1.800.848.1633 Fax Free: 1.800.447.2923 • Web: GoHCL.com • Email: hcl@GoHCL.com Visit www.ksrleads.com/?301hp-008 26 January 2013 • HEALTHCARE PURCHASING NEWS • www.hpnonline.com HealthPurchNewsPullHorz.indd 1


to reduce irritation and restarts; less plastic, which means less waste; saving money by not needing to throw away unused components; a passive safety mechanism requiring no user activation and that cannot be bypassed; design that minimizes needlestick injuries, promot- ing compliance with recommended safety guidelines; a sharp universal needle bevel and double flashback vein-access confirma- tion for greater first-stick success; plus, the Introcan Safety 3 Closed IV Catheter offers an added safety feature with a multi-access


See INFECTION PREVENTION on page 28 11/29/12 3:35 PM


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56